12-02 :: February/March 2012
nanotimes
Companies Facts
Moreover, Arrowhead Research and Axolabsin Germany have entered into a Strategic Alliance and Master Services Agreement. Under the terms of the agreement, Axolabs, founded by the principals of former Roche Center of Excellence for RNAi Thera- peutics in Kulmbach, Germany, will provide Arrow- head and its partners first-in-class oligonucleotide optimization, synthesis, and analytics. These services include bioinformatics for siRNA design; lead iden- tification, optimization and characterization; as well as siRNA synthesis and CMC-related activities.
Arrowhead Research has also released a white paper describing the health problem posed by the hepatitis B virus (HBV), the substantial unmet need for chro- nic HBV infected patients, and how Arrowhead’s Dynamic Polyconjugate (DPC) enabled RNAi the- rapeutic in development could potentially address deficiencies of current treatment options.
http://www.arrowheadresearch.com http://www.axolabs.com
B
ASF Venture Capital GmbH has invested $13.5 million in Allylix Inc., a US-based renewable
chemicals company. The BASF subsidiary led a $18.2 million financing round, joined by existing investors Tate & Lyle Ventures, Avrio Ventures and Cultivian Ventures. Allylix has a proprietary techno- logy platform to produce a wide variety of renew- able specialty chemicals, i.e. terpenes and their derivatives, for several industries including flavor and fragrance, food ingredients, cosmetics and other markets. The technology, based on fermentation, allows for the creation of highly pure, renewable
Because ultraviolet (UV) light attacks polycarbonate at the surface, UV protection is most effective when concentrated there. Yet, with traditional compoun- ding of additives it is not possible to concentrate protection at the surface. This limits UV absorber effectiveness in outdoor applications, such as lenses and covers for lighting fixtures, where protection from sunlight is essential to durability and clarity.
compounds that have previously only been available from natural resources in limited quantities.
http://www.allylix.com http://www.basf-vc.de
environmentally responsible way to improve the UV protection of injection molded or extruded polycar- bonate parts. The company has licensed the tech- nology exclusively to Radco Infusion Technologies LLC, for worldwide use.
A
URA™ infusion technology, developed by Bayer MaterialScience LLC, offers a cost-effective and
15
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89